Clinical Study
Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
Table 1
Univariate analysis of CA19-9 serum level with various clinicopathological features in 304 patients with surgically removed hepatocellular carcinoma.
| Variables | CA19-9 serum level (U/mL) | value | >27 | ≤27 |
| Age | | | 0.2560 | >55 | 72 | 120 | | ≤55 | 34 | 78 | | Gender | | | 0.8097 | Male | 85 | 155 | | Female | 21 | 43 | | HBsAg | | | 0.4840 | Negative | 42 | 70 | | Positive | 60 | 123 | | Anti-HCV | | | 0.2552 | Negative | 68 | 143 | | Positive | 34 | 51 | | -fetoprotein (ng/mL) | | | 0.8732 | ≤200 | 73 | 134 | | >200 | 25 | 50 | | Tumor size (cm) | | | 0.6927 | <5 | 61 | 78 | | ≥5 | 45 | 120 | | Grade | | | 0.7288 | 1-2 | 40 | 70 | | 3~4 | 65 | 128 | | Vascular invasion | | | 0.9864 | No | 68 | 128 | | Yes | 38 | 69 | | Multiple | | | 0.5695 | No | 74 | 145 | | Yes | 32 | 52 | | Stage | | | 0.7495 | I | 55 | 97 | | II~III | 51 | 199 | |
|
|